Latest Announcements

Ceigall India Ltd has announced its unaudited financial results for Q1 FY27, with consolidated revenue growing 15.7% YoY to INR 9,696 million and EBITDA increasing 31.4% to INR 1,434 million, with EBITDA margins improving to 14.8%. The company has also made progress in expanding its presence in emerging infrastructure segments and has strengthened its order book with a strong pipeline of projects.

Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Presentation for Q1 FY27 Investor Meet/Con. Call Updates. The company has registered a healthy revenue growth of over 13% with EBIDTA increasing by more than 30%. The acquisition of Oriflame India's Manufacturing business is expected to expand the company's manufacturing footprint in skincare cosmetics and wellness products.

Affle 3I Ltd reported robust performance for Q1 FY2027 with a consolidated revenue from operations of INR 747.2 crore, an increase of 20.4% y-o-y. EBITDA stood at INR 167.6 crore, an increase of 20.0% y-o-y. PAT increased by 21.7% y-o-y to INR 128.4 crore.

Akums Drugs and Pharmaceuticals Ltd announced its Q1 FY27 results, registering a 13% revenue growth and a 30% increase in EBITDA. The company's CDMO segment saw double-digit volume growth, and the API segment improved its gross margins due to higher non-cepha product sales. The company also announced the acquisition of Oriflame India's manufacturing business for Rs 56 Crore.

Ceigall India Limited has announced its Q1 FY27 financial results, with consolidated revenue increasing 15.7% YoY to INR 9,696 million, EBITDA growing 31.4% YoY to INR 1,434 million, and PAT increasing 24.4% YoY to INR 638 million. The company has also maintained a strong order book of INR 185,683 million as on June 30, 2026.

Ceigall India Limited has released its Q1 FY27 investor presentation, highlighting a 15.7% year-on-year growth in consolidated revenue to INR 9,696 million, with EBITDA increasing 31.4% to INR 1,434 million and EBITDA margins improving to 14.8%. The company has also made progress in expanding its presence in emerging infrastructure segments and has a strong order book of INR 185,683 million.

Akums Drugs and Pharmaceuticals Ltd reported Q1 FY27 financial results with 13.9% YoY revenue growth, 35.4% YoY EBITDA growth, and 55.4% YoY PAT growth.

Akums Drugs and Pharmaceuticals Limited has reported a 13.9% YoY revenue growth in Q1 FY27, with operating revenue of ₹1,167 crore and PAT of ₹101 crore.

Mayur Floorings Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 253.60 crores, a 30.6% increase from the same period last year. The company's net profit for the quarter stood at Rs. 5.55 crores, a 83.3% increase from the same period last year. The company has also completed the trial run of its Ball mill plant during the quarter.

Aditya Birla Fashion and Retail Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a 11% revenue growth and a 2% decline in EBITDA.

Amanta Healthcare Limited held a Q1 FY27 Earnings Conference Call, reporting revenue of INR69 crores, up 5% year-on-year, and maintaining a healthy EBITDA margin of approximately 22%. The company is expanding its manufacturing capabilities and product portfolio, with its SteriPort platform contributing 44% of revenue and expected to witness strong customer acceptance. The expansion of the SteriPort facility has been delayed due to operational issues, but the company remains confident in its growth prospects.

Amanta Healthcare Ltd reported Q1 FY27 earnings with revenue of INR69 crores, up 5% YoY, and EBITDA margin of 22%. The company is expanding its SteriPort capacity and strengthening its small volume SVP portfolio. A 10.8 MW captive solar power project has been commissioned, expected to reduce power cost and improve operating margins.

Nilachal Carbo Metalicks Ltd has informed that the Ministry of Finance has imposed a definitive anti-dumping duty on import of Low Ash Metallurgical Coke originating in or exported from Australia, China PR, Colombia, Indonesia, Japan, and Russia for a period of five years. This policy change is expected to positively impact domestic manufacturers and strengthen market competitiveness.

Nitin Spinners Ltd has reported strong quarterly performance for Q1FY27, with revenue reaching ₹875 crore, marking its highest-ever quarterly revenue for the second consecutive quarter. The performance was driven by improved yarn realizations and better demand. The company remains confident of delivering year-on-year growth for the full year FY27, supported by the commercialization of its additional capacities of fabric and yarn.

Paradeep Phosphates Ltd has informed that the Hon'ble Supreme Court has dismissed the appeal filed by the Department of Fertilizers against the order of Hon'ble High Court of Delhi, upholding the direction to release subsidy claim amounting to ₹53.50 crore to the Company under the Nutrient Based Subsidy (NBS) Scheme.

Delhivery Ltd reported Q1FY27 results with strong volume and revenue growth momentum. Express shipments grew 55.2% YoY, PTL freight tonnage increased 18.4% YoY, and revenue from services stood at Rs.2,931 Cr (+27.8% YoY). Adjusted EBITDA was Rs.76 Cr (2.6% margin), EBITDA was Rs.156 Cr (5.3% margin), and PAT was Rs.62 Cr prior to integration costs. The company maintained a heightened focus on maintaining stable network service quality in the face of a challenging external environment.

Nitin Spinners Limited has informed the Exchange about Investor Presentation, which includes Q1FY27 performance highlights, company overview, capex update, and way forward. The company reports strong quarterly performance with revenue reaching ₹875 crore, marking its highest-ever quarterly revenue for the second consecutive quarter. The performance was driven by improved yarn realizations and better demand. The company remains confident of delivering year-on-year growth for the full year FY27, supported by the commercialization of its additional capacities of fabric and yarn.

Delhivery Limited has informed the Exchange about Letter to Shareholders on financial results for the quarter ended June 30, 2026. The company reported strong volume and revenue growth momentum in Q1FY27, with express parcel shipments and PTL freight tonnage increasing by 55.2% and 18.4% YoY, respectively. Revenue from services stood at Rs.2,931 Cr (+27.8% YoY) with Adjusted EBITDA of Rs.76 Cr (2.6% margin), reported EBITDA of Rs.156 Cr (5.3% margin) and PAT of Rs.62 Cr prior to integration costs.

Apollo Micro Systems Limited has informed the Exchange about General Updates, including a letter to shareholders from the Managing Director, discussing the acquisition of Premier Explosives and the company's aspirations to build institutions that endure.

Apollo Micro Systems Limited has provided a tear sheet of the company, highlighting its achievements and growth in the defence industry, including the sanction of a Make-II prototype order for a 500 Kg Smart Bomb by the Indian Air Force and the empanelment as a Prime Development Agency for the Indigenous Precision Range Extension Kit programme.